Four-Year Incidence of Diabetic Retinopathy in a Spanish Cohort: The MADIABETES Study

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Salinero Fort, Miguel Á ^a   San Andrés Rebollo, Francisco Javier ^a   de Burgos Lunar, Carmen ^a   Arrieta Blanco, Francisco Jesús ^b   Gómez Campelo, Paloma ^a  

^a Servicio Madrileño de Salud Red de Investigación en Servicios de Salud en Enfermedades Crónicas   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ARTICLE; BIOMICROSCOPY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC RETINOPATHY; ETHNIC GROUP; EYE EXAMINATION; FEMALE; GENERAL PRACTITIONER; HEALTH CARE; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; RISK FACTOR; SLIT LAMP; SPAIN; SPANISH;

AGED; COHORT STUDIES; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SPAIN;

EID: 84885747813     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076417     Document Type: Article

References (90)

1. Shotliff K, Davies N (2012) Diabetes and the Eye. In: Shaw KM, Cummings MH, editors. Diabetes. Oxford, UK: Wiley-Blackwell. 1-33. doi: 10.1002/9781118405550.ch1.
2. Moss SE, Klein R, Klein BE, (1998) The 14-year incidence of visual loss in a diabetic population. Ophthalmology 105(6): 998-1003.
3. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, et al. (2004) Global data on visual impairment in the year 2002. Bull World Health Organ 82(11): 844-851.
4. American Diabetes Association (2011) Standards of Medical Care in Diabetes-2012. Diabetes Care 35(Suppl1): S11-S63.
5. Thompson JW, Bost J, Ahmed F, Ingalls CE, Sennett C, (1998) The NCQA's quality compass: evaluating managed care in the United States. Health Aff (Millwood) 17(1): 152-158.
6. Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M, (2007) Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women. Diabetes Care 30(2): 292-299.
7. Tong PCY, Kong AP, So WY, Yang X, Ng MCY, et al. (2007) Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with Type 2 diabetes mellitus. Diabet Med 24(7): 741-746.
8. Targher G, Bertolini L, Zenari L, Lippi G, Pichiri I, et al. (2008) Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients. Diabet Med 25(1): 45-50.
9. Cheung N, Wang JJ, Klein R, Couper DJ, Sharrett AR, et al. (2007) Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Diabetes Care 30(7): 1742-1746.
10. Cheung N, Rogers S, Couper DJ, Klein R, Sharrett AR, et al. (2007) Is diabetic retinopathy an independent risk factor for ischemic stroke? Stroke 38(2): 398-401.
11. Zhang L, Krzentowski G, Albert A, Lefebvre PJ, (2001) Risk of Developing Retinopathy in Diabetes Control and Complications Trial Type 1 Diabetic Patients With Good or Poor Metabolic Control. Diabetes Care 24(7): 1275-1279.
12. Hosseini SM, Maracy MR, Amini M, Baradaran HR, (2009) A risk score development for diabetic retinopathy screening in Isfahan-Iran. J Res Med Sci 14(2): 105-110.
13. de Burgos-Lunar C, Salinero-Fort MA, Cárdenas-Valladolid J, Soto-Díaz S, Fuentes-Rodríguez CY, et al. (2011) Validation of diabetes mellitus and hypertension diagnosis in computerized medical records in primary health care. BMC Med Res Methodol 11: 146.
14. Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, et al. (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110(9): 1677-1682.
15. Grading diabetic retinopathy from stereoscopic color fundus photographs- an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98(5 Suppl): 786-806. (1991).
16. López Gálvez MI, (2004) International severity scale of diabetic retinopathy and diabetic macular edema. Arch Soc Esp Oftalmol 79(4): 149-150.
17. Selvin E, Coresh J, Zhu H, Folsom A, Steffes MW, (2010) Measurement of HbA1c from stored whole blood samples in the Atherosclerosis Risk in Communities study. J Diabetes 2(2): 118-124.
18. Marrugat J, Solanas P, D'Agostino R, Sullivan L, Ordovas J, et al. (2003) Coronary risk estimation in Spain using a calibrated Framingham function. Rev Esp Cardiol 56(3): 253-261.
19. Bosomworth NJ, (2011) Practical use of the Framingham risk score in primary prevention: Canadian perspective. Can Fam Physician 57(4): 417-423.
20. Domenech JM, Navarro JB (2008) Análisis de la supervivencia y modelo de riesgos proporcionales de Cox. Barcelona: Signo.
21. Dwyer MS, Melton LJ 3rd, Ballard DJ, Palumbo PJ, Trautmann JC, et al. (1985) Incidence of diabetic retinopathy and blindness: a population-based study in Rochester, Minnesota. Diabetes Care 8(4): 316-322.
22. Varma R, Choudhury F, Klein R, Chung J, Torres M, et al. (2010) Four-year incidence and progression of diabetic retinopathy and macular edema: the Los Angeles Latino Eye Study. Am J Ophthalmol 149(5): 752-761.
23. Tudor SM, Hamman RF, Baron A, Johnson DW, Shetterly SM, (1998) Incidence and progression of diabetic retinopathy in Hispanics and non-Hispanic whites with type 2 diabetes. San Luis Valley Diabetes Study, Colorado. Diabetes Care 21(1): 53-61.
24. Pugliese G, Solini A, Zoppini G, Fondelli C, Zerbini G, et al. (2012) High prevalence of advanced retinopathy in patients with type 2 diabetes from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study. Diabetes Res Clin Pract 25: S0168-8227(12)00310-5.
25. Gimeno-Orna JA, Castro-Alonso FJ, Boned-Juliani B, Lou-Arnal LM, (2003) Fasting plasma glucose variability as a risk factor of retinopathy in Type 2 diabetic patients. J Diabetes Complicat 17(2): 78-81.
26. Nathan DM, Zinman B, Cleary PA, Backlund J-YC, Genuth S, et al. (2009) Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005). Arch Intern Med 169(14): 1307-1316.
27. Brown JB, Pedula KL, Summers KH, (2003) Diabetic retinopathy: contemporary prevalence in a well-controlled population. Diabetes Care 26(9): 2637-2642.
28. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL, (1984) The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102(4): 527-532.
29. Tapp RJ, Tikellis G, Wong TY, Harper CA, Zimmet PZ, et al. (2008) Longitudinal association of glucose metabolism with retinopathy: results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Diabetes Care 31(7): 1349-1354.
30. Leske MC, Wu S-Y, Hennis A, Nemesure B, Hyman L, et al. (2003) Incidence of diabetic retinopathy in the Barbados Eye Studies. Ophthalmology 110(5): 941-947.
31. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL, (1989) The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol 107(2): 244-249.
32. Cikamatana L, Mitchell P, Rochtchina E, Foran S, Wang JJ, (2007) Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study. Eye (Lond) 21(4): 465-471.
33. McCarty DJ, Fu CL, Harper CA, Taylor HR, McCarty CA, (2003) Five-year incidence of diabetic retinopathy in the Melbourne Visual Impairment Project. Clin Experiment Ophthalmol 31(5): 397-402.
34. Liu DP, Molyneaux L, Chua E, Wang YZ, Wu CR, et al. (2002) Retinopathy in a Chinese population with type 2 diabetes: factors affecting the presence of this complication at diagnosis of diabetes. Diabetes Res Clin Pract 56(2): 125-131.
35. Tam VHK, Lam EPK, Chu BCY, Tse KK, Fung LM, (2009) Incidence and progression of diabetic retinopathy in Hong Kong Chinese with type 2 diabetes mellitus. J Diabetes Complicat 23(3): 185-193.
36. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BEK, (2008) The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXII. Ophthalmology 115(11): 1859-1868.
37. Leske MC, Wu S-Y, Hennis A, Nemesure B, Schachat AP, et al. (2006) Nine-year incidence of diabetic retinopathy in the Barbados Eye Studies. Arch Ophthalmol 124(2): 250-255.
38. Wong TY, Klein R, Islam FMA, Cotch MF, Folsom AR, et al. (2006) Diabetic Retinopathy in a Multi-ethnic Cohort in the United States. Am J Ophthalmol 141(3): 446-455.
39. Teruel Maicas C, Fernández-Real J, Ricart W, Valent Ferrer R, Vallés Prats M (2005) Prevalencia de la retinopatía diabética en la población de diabéticos diagnosticados en las comarcas de Girona: Estudio de los factores asociados. Archivos de la Sociedad Española de Oftalmología [Internet] 80(2). Scielo website. Available: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0365-66912005000200006&lng=en&nrm=iso&tlng=en Accessed 2013 Feb 25.
40. Santos-Bueso E, Fernández-Pérez C, Macarro A, Fernández-Vigo J (2007) Prevalencia de retinopatía diabética en la ciudad de Badajoz 2002 (Proyecto Extremadura para prevención de la ceguera). Archivos de la Sociedad Española de Oftalmología [Internet] 82(3). Scielo website. Available: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0365-66912007000300007&lng=en&nrm=iso&tlng=en Accessed 2013 Mar 29.
41. Güven D, Ozdemir H, Hasanreisoglu B, (1996) Hemodynamic alterations in diabetic retinopathy. Ophthalmology 103(8): 1245-9.
42. Wang S, Xu L, Jonas JB, Wang YX, You QS, et al. (2012) Dyslipidemia and Eye Diseases in the Adult Chinese Population: The Beijing Eye Study. Federici M, editor. PLoS ONE 7(3): e26871.
43. Benarous R, Sasongko MB, Qureshi S, Fenwick E, Dirani M, et al. (2011) Differential association of serum lipids with diabetic retinopathy and diabetic macular edema. Invest Ophthalmol Vis Sci 52(10): 7464-7469.
44. Romero-Aroca P, Baget-Bernaldiz M, Reyes-Torres J, Fernandez-Ballart J, Plana-Gil N, et al. (2012) Relationship between diabetic retinopathy, microalbuminuria and overt nephropathy, and twenty-year incidence follow-up of a sample of type 1 diabetic patients. J Diabetes Complications 26(6): 506-512.
45. Lyons TJ, Jenkins AJ, Zheng D, Lackland DT, McGee D, et al. (2004) Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. Invest Ophthalmol Vis Sci 45(3): 910-918.
46. Simpson SH, Gamble J-M, Mereu L, Chambers T, (2011) Effect of aspirin dose on mortality and cardiovascular events in people with diabetes: a meta-analysis. J Gen Intern Med 26(11): 1336-1344.
47. Bergerhoff K, Clar C, Richter B, (2002) Aspirin in diabetic retinopathy. A systematic review. Endocrinol Metab Clin North Am 31(3): 779-793.
48. Klein BE, Howard KP, Gangnon RE, Dreyer JO, Lee KE, et al. (2012) Long-term use of aspirin and age-related macular degeneration. JAMA 308(23): 2469-78.
49. Zhu W, Wu Y, Xu D, Li YH, Jun B, et al. (2013) Aspirin use and risk of age-related macular degeneration: a meta-analysis. PLoS One 8(3): e58821.
50. Pignone M, Williams CD, (2010) Aspirin for primary prevention of cardiovascular disease in diabetes mellitus. Nat Rev Endocrinol 6(11): 619-28.
51. Klein R, Klein BE, Moss SE, Linton KL, (1992) The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. Ophthalmology 99(1): 58-62.
52. van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, et al. (2003) Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol 121(2): 245-251.
53. Hirsch IB, Brownlee M, (2010) Beyond hemoglobin A1c-need for additional markers of risk for diabetic microvascular complications. JAMA 303(22): 2291-2292.
54. Liu QZ, Pettitt DJ, Hanson RL, Charles MA, Klein R, et al. (1993) Glycated haemoglobin, plasma glucose and diabetic retinopathy: cross-sectional and prospective analyses. Diabetologia 36(5): 428-432.
55. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL, (1988) Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 260(19): 2864-2871.
56. Klein R, Klein BE, Moss SE, Cruickshanks KJ, (1994) Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med 154(19): 2169-2178.
57. Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, et al. (2001) UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 44(2): 156-163.
58. Chen MS, Kao CS, Fu CC, Chen CJ, Tai TY, (1995) Incidence and progression of diabetic retinopathy among non-insulin-dependent diabetic subjects: a 4-year follow-up. Int J Epidemiol 24(4): 787-795.
59. Kim HK, Kim CH, Kim SW, Park JY, Hong SK, et al. (1998) Development and progression of diabetic retinopathy in Koreans with NIDDM. Diabetes Care 21(1): 134-138.
60. Looker HC, Krakoff J, Knowler WC, Bennett PH, Klein R, et al. (2003) Longitudinal studies of incidence and progression of diabetic retinopathy assessed by retinal photography in pima indians. Diabetes Care 26(2): 320-326.
61. Tam TKW, Lau CM, Tsang LCY, Ng KK, Ho KS, et al. (2005) Epidemiological study of diabetic retinopathy in a primary care setting in Hong Kong. Hong Kong Med J 11(6): 438-444.
62. Leske MC, Wu S-Y, Hennis A, Hyman L, Nemesure B, et al. (2005) Hyperglycemia, blood pressure, and the 9-year incidence of diabetic retinopathy: the Barbados Eye Studies. Ophthalmology 112(5): 799-805.
63. Klein R (2008) The Epidemiology of Diabetic Retinopathy. In: Duh EJ, editor. Diabetic Retinopathy. Totowa, NJ: Humana Press. 67-107. Springer website. Available: http://www.springerlink.com/index/10.1007/978-1-59745-563-3_3 Accessed 2013 Apr 10.
64. Kohner EM (2008) Microvascular disease: what does the UKPDS tell us about diabetic retinopathy? Diabet Med (Suppl 2): 20-24.
65. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352(9131): 837-853.
66. Thomas RL, Dunstan F, Luzio SD, Roy Chowdury S, Hale SL, et al. (2012) Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis. BMJ 344: e874.
67. Manaviat MR, Rashidi M, Afkhami-Ardekani M, (2008) Four years incidence of diabetic retinopathy and effective factors on its progression in type II diabetes. Eur J Ophthalmol 18(4): 572-577.
68. Younis N, Broadbent DM, Vora JP, Harding SP, (2003) Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 361(9353): 195-200.
69. Tapp RJ, Zimmet PZ, Harper CA, McCarty DJ, Chitson P, et al. (2006) Six year incidence and progression of diabetic retinopathy: results from the Mauritius diabetes complication study. Diabetes Res Clin Pract 73(3): 298-303.
70. Knowler WC, Bennett PH, Ballintine EJ, (1980) Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians. N Engl J Med 302(12): 645-650.
71. UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317(7160): 703-713.
72. Estacio RO, Jeffers BW, Gifford N, Schrier RW (2000) Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care (Suppl 2): B54-64.
73. Chew EY, Ambrosius WT, Davis MD, Danis RP, Gangaputra S, et al. (2010) Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 363(3): 233-244.
74. Newman DJ, Mattock MB, Dawnay ABS, Kerry S, McGuire A, et al. (2005) Systematic review on urine albumin testing for early detection of diabetic complications. Health Technol Assess 9(30): iii-vi, xiii-163.
75. Raman R, Gupta A, Kulothungan V, Sharma T, (2012) Prevalence and risk factors of diabetic retinopathy in subjects with suboptimal glycemic, blood pressure and lipid control. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, Report 33). Curr Eye Res 37(6): 513-523.
76. Perol J, Balkau B, Guillausseau P-J, Massin P, (2012) A study of the 3-year incidence of diabetic retinopathy in a French diabetic population seen at Lariboisière Hospital, Paris. Diabetes Metab 38(3): 225-229.
77. Chen Y-H, Chen H-S, Tarng D-C, (2012) More impact of microalbuminuria on retinopathy than moderately reduced GFR among type 2 diabetic patients. Diabetes Care 35(4): 803-808.
78. Vigstrup J, Mogensen CE, (1985) Proliferative diabetic retinopathy: at risk patients identified by early detection of microalbuminuria. Acta Ophthalmol (Copenh) 63(5): 530-534.
79. Gall MA, Rossing P, Skøtt P, Damsbo P, Vaag A, et al. (1991) Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 34(9): 655-661.
80. Manaviat MR, Afkhami M, Shoja MR, (2004) Retinopathy and microalbuminuria in type II diabetic patients. BMC Ophthalmol 4: 9.
81. Rani PK, Raman R, Gupta A, Pal SS, Kulothungan V, et al. (2011) Albuminuria and Diabetic Retinopathy in Type 2 Diabetes Mellitus Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 12). Diabetol Metab Syndr (1): 9.
82. Ajoy Mohan VK, Nithyanandam S, Idiculla J, (2011) Microalbuminuria and low hemoglobin as risk factors for the occurrence and increasing severity of diabetic retinopathy. Indian J Ophthalmol 59(3): 207-210.
83. Singh SK, Behre A, Singh MK, (2001) Diabetic retinopathy and microalbuminuria in lean type 2 diabetes mellitus. J Assoc Physicians India 49: 439-441.
84. Potisat S, Srisubat A, Krairttichai U, Jongsareejit A, (2008) The relationship between microalbuminuria by using urine dipsticks and diabetic retinopathy in type 2 diabetes. J Med Assoc Thai 91(6): 846-851.
85. Voutilainen-Kaunisto RM, Teräsvirta ME, Uusitupa MI, Niskanen LK, (2001) Occurrence and predictors of retinopathy and visual acuity in Type 2 diabetic patients and control subjects. J Diabetes Complications 15(1): 24-33.
86. Cignarelli M, De Cicco ML, Damato A, Paternostro A, Pagliarini S, et al. (1992) High systolic blood pressure increases prevalence and severity of retinopathy in NIDDM patients. Diabetes Care 15(8): 1002-1008.
87. Unnikrishnan RI, Rema M, Pradeepa R, Deepa M, Shanthirani CS, et al. (2007) Prevalence and risk factors of diabetic nephropathy in an urban South Indian population: the Chennai Urban Rural Epidemiology Study (CURES 45). Diabetes Care 30(8): 2019-2024.
88. Wirta OR, Pasternack AI, Oksa HH, Mustonen JT, Koivula TA, et al. (1995) Occurrence of late specific complications in type II (non-insulin-dependent) diabetes mellitus. J Diabetes Complicat 9(3): 177-185.
89. Bruno G, Cavallo-Perin P, Bargero G, Borra M, Calvi V, et al. (1996) Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects. Diabetes Care 19(1): 43-47.
90. Klein R, Klein BE, Moss SE, (1993) Prevalence of microalbuminuria in older-onset diabetes. Diabetes Care 16(10): 1325-1330.